Yanli Nie

590 total citations · 1 hit paper
17 papers, 450 citations indexed

About

Yanli Nie is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yanli Nie has authored 17 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Yanli Nie's work include Medical Malpractice and Liability Issues (3 papers), Patient Safety and Medication Errors (3 papers) and Cancer Diagnosis and Treatment (3 papers). Yanli Nie is often cited by papers focused on Medical Malpractice and Liability Issues (3 papers), Patient Safety and Medication Errors (3 papers) and Cancer Diagnosis and Treatment (3 papers). Yanli Nie collaborates with scholars based in China and Hungary. Yanli Nie's co-authors include Hao Cui, Mingming Zhang, Jing Li, Xuanyue Mao, Qiongwen Zhang, Sheng Hu, Min Jiao, Kejun Nan, Wei Zhao and Lu Li and has published in prestigious journals such as ACS Applied Materials & Interfaces, Molecular Cancer and Medicine.

In The Last Decade

Yanli Nie

13 papers receiving 416 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hospital survey on patient safety culture in China

2013 325 citations Yanli Nie, Xuanyue Mao et al. BMC Health Services Research profile →

Peers

Countries citing papers authored by Yanli Nie

Since Specialization

Citations

This map shows the geographic impact of Yanli Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Nie more than expected).

Fields of papers citing papers by Yanli Nie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Nie. The network helps show where Yanli Nie may publish in the future.

Co-authorship network of co-authors of Yanli Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Nie. A scholar is included among the top collaborators of Yanli Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Nie. Yanli Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Prognostic value of neutrophil-to-lymphocyte ratio and CA 19–9 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy 2025 ·World Journal of Surgical Oncology ·Yanli Nie, (unknown), (unknown), Fang Guo, Xin Jin, (unknown)	0
2	Rapid diagnosis of adult-type diffuse glioma using a layered scheme 2025 ·BMC Medicine ·Jinsong Wu, Shuai Wu, (unknown), (unknown), Jianhua Zhang, (unknown), Zanyi Wu, Yanli Nie, (unknown), Ye Yao, Yanyan Song, Yuchen Jiao, Hong Chen, Hui Ma, (unknown), Ying Mao, Hai Yan	0
3	Partial response to posterior line immunotherapy for more than 15 months in a pMMR patient with cutaneous metastasis of rectal carcinoma: a case report 2025 ·Therapeutic Advances in Gastroenterology ·(unknown), Pengfei Xu, Yanli Nie	0
4	Integration of multiomics features for blood-based early detection of colorectal cancer 2024 ·Molecular Cancer ·Yibo Gao, Dandan Cao, Mengfan Li, Fuqiang Zhao, (unknown), (unknown), Qianqian Song, (unknown), Yanli Nie, Wei Zhao, Sizhen Wang, Hai Yan, Xishan Wang, Yuchen Jiao, Qian Liu	16
5	2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in mediastinum: a case report 2023 ·Frontiers in Oncology ·Wei Zhao, Nan Zhao, (unknown), Zhihua Li, (unknown), Ning Wang, (unknown), (unknown), Yanli Nie, Zhaoxia Li	0
6	Predictive biomarkers and new developments of immunotherapy in gastric cancer: a 2023 update. 2023 ·PubMed ·Yanli Nie, Wei Zhao, Lu Li, Fuxiang Zhou	13
7	Manganese Dioxide/Gold-based Active Tumor Targeting Nanoprobes for Enhancing Photodynamic and Low-Temperature-Photothermal Combination Therapy in Lung Cancer 2023 ·ACS Applied Materials & Interfaces ·Yanyan Liu, Yue Huang, (unknown), Yifei Ma, (unknown), (unknown), (unknown), Hongli Xu, Yanli Nie, Jing Luo, (unknown), Xinjun Liang	13
8	Apatinib plus 5-fluorouracil as a third or subsequent-line treatment option for metastatic colorectal cancer: a phase-II, single-arm, prospective study 2022 ·Annals of Translational Medicine ·Runzhi Chen, Yang Liu, Sheng Hu, (unknown), Yanli Nie, Hongli Xu, Yi Zhong, (unknown), Xinjun Liang, Huiting Xu	6
9	WASF3 Knockdown Sensitizes Gastric Cancer Cells to Oxaliplatin by Inhibiting ATG12-Mediated Autophagy 2020 ·The American Journal of the Medical Sciences ·Yanli Nie, Xinjun Liang, (unknown), Fang Guo, Na Fang, Fuxiang Zhou	13
10	Complete response to sunitinib for more than three years in a patient with a jejunum gastrointestinal stromal tumor 2019 ·Medicine ·Yanli Nie, Wenjia Sun, Zhihua Xiao, (unknown)	2
11	Wasf3 Expression Correlates With Poor Prognosis In Gastric Cancer Patients 2019 ·Future Oncology ·Yanli Nie, Sheng Hu, (unknown), Na Fang, Fang Guo, Yang Liu, Xinjun Liang	5
12	A novel small inhibitor, LLL12, targets STAT3 in non‑small cell lung cancer in�vitro and in�vivo 2018 ·Oncology Letters ·Yanli Nie, Yuanyuan Li, Sheng Hu	7
13	Hospital survey on patient safety culture in China breakdown → 2013 ·BMC Health Services Research ·Yanli Nie, Xuanyue Mao, Hao Cui, (unknown), Jing Li, Mingming Zhang	325
14	Antiproliferative Activity of the Chinese Medicinal Compound, Delisheng, Compared With Rg3 and Gemcitabine in HepG2 Cells. 2013 ·PubMed ·(unknown), (unknown), Yanli Nie, (unknown), Haifeng Sun, (unknown), Kejun Nan	8
15	Literature review regarding patient safety culture 2013 ·Journal of Evidence-Based Medicine ·(unknown), Yanli Nie, Hao Cui, (unknown), Qiongwen Zhang	21
16	Patient Safety Research in China: A Literature Review 2011 ·Journal of Evidence-Based Medicine ·Yanli Nie, Yulin Li, (unknown), (unknown), Yan Huang, Mingming Zhang	7
17	Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways 2009 ·Molecular Biology Reports ·(unknown), Kejun Nan, Yanli Nie, (unknown), Min Jiao	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact